Empiric vancomycin use in febrile neutropenic oncology patients.
Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising concern for antibiotic resistance and prompting opportunities for improvement.
Virginia Commonwealth University School of Pharmacy, Falls Church, Virginia.
Jessica
J
Libuit
Virginia Commonwealth University School of Pharmacy, Falls Church, Virginia.
Andrew
A
Whitman
Virginia Commonwealth University School of Pharmacy, Falls Church, Virginia.
Rebecca
R
Wolfe
Virginia Commonwealth University School of Pharmacy, Falls Church, Virginia ; Department of Pharmacotherapy and Outcome Sciences.
Casey S
CS
Washington
antibiotics; empiric; febrile neutropenia; oncology; vancomycin